Bandingkan Harga & Kinerja Multi Prima Sejahtera Tbk (LPIN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multi Prima Sejahtera Tbk dan Organon Pharma Indonesia Tbk.: Multi Prima Sejahtera Tbk diperdagangkan di Rp428 (kapitalisasi pasar 183,6 M, volume 24 jam 77 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multi Prima Sejahtera Tbk lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| LPIN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 183,6 M | 104,4 M |
Volume | 77 rb | — |
Lot | 770 | — |
Perputaran | 33,12 jt | — |
Harga Rata-rata | 430,17 | — |
Nilai Transaksi | 33,12 jt | — |
Harga Ekuilibrium Indikatif | 434 | — |
Volume Ekuilibrium Indikatif | 7 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multi Prima Sejahtera Tbk
PT Multi Prima Sejahtera Tbk was established in January 7, 1982, PT Lippo Industries is licensed producer of spark-plug under the Champion trade mark. It has 7 subsidiaries In 1996, it joint venture with Kwan Yang Motor Company, Taiwan to established a motorcycle manufacturing. And on AEGM on June 27th 2001, the meeting decide to change the company's name to Multi Prima Sejahtera Tbk.
Selengkapnya di halaman LPIN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
